TWI801370B - 用於評估糖尿病循環併發症之光學量測系統及估計組織血管健康之方法 - Google Patents
用於評估糖尿病循環併發症之光學量測系統及估計組織血管健康之方法 Download PDFInfo
- Publication number
- TWI801370B TWI801370B TW107109908A TW107109908A TWI801370B TW I801370 B TWI801370 B TW I801370B TW 107109908 A TW107109908 A TW 107109908A TW 107109908 A TW107109908 A TW 107109908A TW I801370 B TWI801370 B TW I801370B
- Authority
- TW
- Taiwan
- Prior art keywords
- tissue
- light
- vascular health
- diabetes
- estimates
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 88
- 230000003287 optical effect Effects 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 44
- 238000005259 measurement Methods 0.000 title claims abstract description 42
- 230000006438 vascular health Effects 0.000 title claims abstract description 38
- 238000009826 distribution Methods 0.000 claims abstract description 29
- 108010054147 Hemoglobins Proteins 0.000 claims abstract description 26
- 102000001554 Hemoglobins Human genes 0.000 claims abstract description 26
- 238000005286 illumination Methods 0.000 claims abstract description 22
- 238000004891 communication Methods 0.000 claims abstract description 10
- 238000003384 imaging method Methods 0.000 claims description 37
- 208000025865 Ulcer Diseases 0.000 claims description 35
- 231100000397 ulcer Toxicity 0.000 claims description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 21
- 229910052760 oxygen Inorganic materials 0.000 claims description 21
- 239000001301 oxygen Substances 0.000 claims description 21
- 238000001514 detection method Methods 0.000 claims description 11
- 230000002452 interceptive effect Effects 0.000 claims description 4
- 239000013307 optical fiber Substances 0.000 claims 1
- 238000012546 transfer Methods 0.000 abstract description 8
- 210000001519 tissue Anatomy 0.000 description 134
- 210000002683 foot Anatomy 0.000 description 53
- 230000010412 perfusion Effects 0.000 description 27
- 208000018262 Peripheral vascular disease Diseases 0.000 description 26
- 230000004087 circulation Effects 0.000 description 26
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 230000002792 vascular Effects 0.000 description 15
- 238000010521 absorption reaction Methods 0.000 description 14
- 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 13
- 230000036541 health Effects 0.000 description 13
- 201000005572 sensory peripheral neuropathy Diseases 0.000 description 13
- 206010040030 Sensory loss Diseases 0.000 description 12
- 210000004207 dermis Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000006213 oxygenation reaction Methods 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 150000003278 haem Chemical class 0.000 description 8
- 230000001771 impaired effect Effects 0.000 description 8
- 208000019553 vascular disease Diseases 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000009257 reactivity Effects 0.000 description 7
- 230000001457 vasomotor Effects 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 230000001747 exhibiting effect Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 6
- 230000036269 ulceration Effects 0.000 description 6
- 101100366935 Caenorhabditis elegans sto-2 gene Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 210000002565 arteriole Anatomy 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000036571 hydration Effects 0.000 description 5
- 238000006703 hydration reaction Methods 0.000 description 5
- 230000001678 irradiating effect Effects 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000011176 pooling Methods 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000000451 tissue damage Effects 0.000 description 5
- 231100000827 tissue damage Toxicity 0.000 description 5
- 210000000264 venule Anatomy 0.000 description 5
- 206010011985 Decubitus ulcer Diseases 0.000 description 4
- 206010020565 Hyperaemia Diseases 0.000 description 4
- 208000004210 Pressure Ulcer Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 230000003542 behavioural effect Effects 0.000 description 3
- 230000002051 biphasic effect Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000002647 laser therapy Methods 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000013517 stratification Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000000287 tissue oxygenation Effects 0.000 description 3
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 2
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 2
- 208000008960 Diabetic foot Diseases 0.000 description 2
- 238000000342 Monte Carlo simulation Methods 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 208000021328 arterial occlusion Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 108010002255 deoxyhemoglobin Proteins 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 210000000452 mid-foot Anatomy 0.000 description 2
- 230000037230 mobility Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000002981 neuropathic effect Effects 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 230000036555 skin type Effects 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000019028 Epidermal thickening Diseases 0.000 description 1
- 208000003790 Foot Ulcer Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010050502 Neuropathic ulcer Diseases 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 206010036155 Poor peripheral circulation Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 208000006906 Vascular Ring Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 208000022064 reactive hyperemia Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000009724 venous congestion Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/447—Skin evaluation, e.g. for skin disorder diagnosis specially adapted for aiding the prevention of ulcer or pressure sore development, i.e. before the ulcer or sore has developed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0064—Body surface scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/486—Biofeedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/7425—Displaying combinations of multiple images regardless of image source, e.g. displaying a reference anatomical image with a live image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
- A61B5/748—Selection of a region of interest, e.g. using a graphics tablet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/22—Arrangements of medical sensors with cables or leads; Connectors or couplings specifically adapted for medical sensors
- A61B2562/221—Arrangements of sensors with cables or leads, e.g. cable harnesses
- A61B2562/223—Optical cables therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0073—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by tomography, i.e. reconstruction of 3D images from 2D projections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02042—Determining blood loss or bleeding, e.g. during a surgical procedure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762475059P | 2017-03-22 | 2017-03-22 | |
| US62/475,059 | 2017-03-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201839379A TW201839379A (zh) | 2018-11-01 |
| TWI801370B true TWI801370B (zh) | 2023-05-11 |
Family
ID=63585758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW107109908A TWI801370B (zh) | 2017-03-22 | 2018-03-22 | 用於評估糖尿病循環併發症之光學量測系統及估計組織血管健康之方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11751769B2 (enExample) |
| EP (1) | EP3573521B1 (enExample) |
| JP (1) | JP7311424B2 (enExample) |
| KR (1) | KR102597974B1 (enExample) |
| CN (1) | CN110573064B (enExample) |
| CA (1) | CA3055768A1 (enExample) |
| SG (1) | SG11201908706QA (enExample) |
| TW (1) | TWI801370B (enExample) |
| WO (1) | WO2018175787A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3106626A1 (en) | 2018-07-16 | 2020-01-23 | Bbi Medical Innovations, Llc | Perfusion and oxygenation measurement |
| EP3866675A4 (en) * | 2018-10-15 | 2022-07-06 | Podimetrics, Inc. | IPSILATERAL ULCER AND METHODS AND DEVICE FOR DETECTING PRE-ULCERATIONS |
| CN111265188A (zh) * | 2020-01-21 | 2020-06-12 | 温州医科大学 | 一种基于局部微循环的糖尿病足风险评估装置及方法 |
| KR102535884B1 (ko) | 2020-05-06 | 2023-05-24 | 고려대학교 산학협력단 | 당뇨병성 합병증 모니터링 장치 및 이를 이용하는 당뇨병성 합병증 관리 시스템 |
| US12419521B2 (en) | 2020-08-21 | 2025-09-23 | Empo Health, Inc. | System to detect foot abnormalities |
| TWI758219B (zh) * | 2021-08-10 | 2022-03-11 | 國立臺灣科技大學 | 遠紅外線的生物效應的評估方法 |
| CN113974580A (zh) * | 2021-10-29 | 2022-01-28 | 苏州爱琴生物医疗电子有限公司 | 一种基于nirs技术的颈动脉狭窄程度分析方法 |
| CA3238042A1 (en) | 2021-12-06 | 2023-06-15 | Podimetrics, Inc. | Apparatus and method of measuring blood flow in the foot |
| KR102781515B1 (ko) * | 2022-04-08 | 2025-03-14 | (주)파인헬스케어 | 병원에서 욕창 상태를 결정하고 치료하기 위한 장치 및 장치의 동작 방법 |
| KR102780364B1 (ko) * | 2022-06-28 | 2025-03-12 | 계명대학교 산학협력단 | 모바일 카메라로 혈류의 양을 측정하여 욕창을 진단할 수 있는 인공지능 기반 욕창 진단 장치 및 시스템 |
| US20240081682A1 (en) * | 2022-09-14 | 2024-03-14 | Hbt Co., Ltd. | System for diagnosing a foot condition by scanning the foot and a method for diagnosing the foot condition using the same |
| EP4618828A1 (en) * | 2022-11-15 | 2025-09-24 | Biotronik Ag | An ai based system for monitoring of peripheral vascular disease patients |
| CN116671997A (zh) * | 2023-05-30 | 2023-09-01 | 无锡海斯凯尔医学技术有限公司 | 组织旋切路径的确定方法、装置及可读存储介质 |
| CN116831528A (zh) * | 2023-06-29 | 2023-10-03 | 北京理工大学 | 一种基于高光谱重建的多尺度信息融合的糖尿病足预测方法 |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070024946A1 (en) * | 2004-12-28 | 2007-02-01 | Panasyuk Svetlana V | Hyperspectral/multispectral imaging in determination, assessment and monitoring of systemic physiology and shock |
| TWI324686B (en) * | 2001-01-26 | 2010-05-11 | Sensys Medcial Inc | Noninvasive measurement of glucose through the optical properties of tissue |
| US20140018649A1 (en) * | 2011-03-31 | 2014-01-16 | Region Midtjylland | System for assessing tissue substance extraction |
| US20140213910A1 (en) * | 2013-01-25 | 2014-07-31 | The Regents Of The University Of California | Method and apparatus for performing qualitative and quantitative analysis of burn extent and severity using spatially structured illumination |
| US20140257113A1 (en) * | 2006-06-30 | 2014-09-11 | Svetlana Panasyuk | Oxyvu-1 hyperspectral tissue oxygenation (hto) measurement system |
| US20140268163A1 (en) * | 2010-11-30 | 2014-09-18 | Thomas E. Milner | Methods and Apparatus Related to Multi Wavelength Photothermal Optical Coherence Tomography |
| US8868157B1 (en) * | 2011-11-09 | 2014-10-21 | VisionQuest Biomedical LLC | Thermal optical imager system and method for detection of peripheral neuropathy |
| US20150265150A1 (en) * | 2014-03-21 | 2015-09-24 | Mark Anthony Darty | Systems and methods for performing an imaging test under constrained conditions |
| US20160069743A1 (en) * | 2014-06-18 | 2016-03-10 | Innopix, Inc. | Spectral imaging system for remote and noninvasive detection of target substances using spectral filter arrays and image capture arrays |
| TW201734429A (zh) * | 2016-02-12 | 2017-10-01 | 摩杜雷特影像公司 | 用於評估組織血管健康之方法及裝置 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1272101A2 (en) * | 2000-04-13 | 2003-01-08 | National Research Council of Canada Ltd. | Tissue viability/health monitor utilizing near infrared spectroscopy |
| US7920908B2 (en) * | 2003-10-16 | 2011-04-05 | David Hattery | Multispectral imaging for quantitative contrast of functional and structural features of layers inside optically dense media such as tissue |
| US8548570B2 (en) * | 2004-11-29 | 2013-10-01 | Hypermed Imaging, Inc. | Hyperspectral imaging of angiogenesis |
| US8374682B2 (en) * | 2005-04-04 | 2013-02-12 | Hypermed Imaging, Inc. | Hyperspectral imaging in diabetes and peripheral vascular disease |
| US8971984B2 (en) * | 2005-04-04 | 2015-03-03 | Hypermed Imaging, Inc. | Hyperspectral technology for assessing and treating diabetic foot and tissue disease |
| US8116838B2 (en) * | 2007-11-27 | 2012-02-14 | Carnegie Mellon University | Medical device for diagnosing pressure ulcers |
| US20100210931A1 (en) * | 2008-04-04 | 2010-08-19 | Modulate Imaging Inc. | Method for performing qualitative and quantitative analysis of wounds using spatially structured illumination |
| US8812083B2 (en) * | 2008-04-21 | 2014-08-19 | Philadelphia Health & Education Corporation | Methods of optically monitoring wound healing |
| US20100312076A1 (en) * | 2009-06-03 | 2010-12-09 | Bly Deborah C | Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof |
| WO2011063306A1 (en) | 2009-11-19 | 2011-05-26 | Modulated Imaging Inc. | Method and apparatus for analysis of turbid media via single-element detection using structured illumination |
| JP2013202303A (ja) * | 2012-03-29 | 2013-10-07 | Hiroshi Oda | 磁気治療器 |
| EP3401678B1 (en) * | 2012-11-07 | 2020-04-08 | Modulated Imaging Inc. | Efficient modulated imaging |
| US20140276014A1 (en) * | 2013-03-13 | 2014-09-18 | Cephalogics, LLC | Supports for optical sensors and related apparatus and methods |
| WO2015143417A1 (en) * | 2014-03-21 | 2015-09-24 | Hypermed Imaging, Inc. | Systems and methods for measuring tissue oxygenation |
| US20150327777A1 (en) * | 2014-05-14 | 2015-11-19 | Stryker Corporation | Tissue monitoring apparatus and system |
-
2018
- 2018-03-22 WO PCT/US2018/023856 patent/WO2018175787A1/en not_active Ceased
- 2018-03-22 JP JP2019551600A patent/JP7311424B2/ja active Active
- 2018-03-22 TW TW107109908A patent/TWI801370B/zh active
- 2018-03-22 KR KR1020197031098A patent/KR102597974B1/ko active Active
- 2018-03-22 CN CN201880019801.9A patent/CN110573064B/zh active Active
- 2018-03-22 SG SG11201908706Q patent/SG11201908706QA/en unknown
- 2018-03-22 EP EP18771715.2A patent/EP3573521B1/en active Active
- 2018-03-22 CA CA3055768A patent/CA3055768A1/en active Pending
-
2019
- 2019-09-09 US US16/565,045 patent/US11751769B2/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI324686B (en) * | 2001-01-26 | 2010-05-11 | Sensys Medcial Inc | Noninvasive measurement of glucose through the optical properties of tissue |
| US20070024946A1 (en) * | 2004-12-28 | 2007-02-01 | Panasyuk Svetlana V | Hyperspectral/multispectral imaging in determination, assessment and monitoring of systemic physiology and shock |
| US20140257113A1 (en) * | 2006-06-30 | 2014-09-11 | Svetlana Panasyuk | Oxyvu-1 hyperspectral tissue oxygenation (hto) measurement system |
| US20140268163A1 (en) * | 2010-11-30 | 2014-09-18 | Thomas E. Milner | Methods and Apparatus Related to Multi Wavelength Photothermal Optical Coherence Tomography |
| US20140018649A1 (en) * | 2011-03-31 | 2014-01-16 | Region Midtjylland | System for assessing tissue substance extraction |
| US8868157B1 (en) * | 2011-11-09 | 2014-10-21 | VisionQuest Biomedical LLC | Thermal optical imager system and method for detection of peripheral neuropathy |
| US20140213910A1 (en) * | 2013-01-25 | 2014-07-31 | The Regents Of The University Of California | Method and apparatus for performing qualitative and quantitative analysis of burn extent and severity using spatially structured illumination |
| US20150265150A1 (en) * | 2014-03-21 | 2015-09-24 | Mark Anthony Darty | Systems and methods for performing an imaging test under constrained conditions |
| US20160069743A1 (en) * | 2014-06-18 | 2016-03-10 | Innopix, Inc. | Spectral imaging system for remote and noninvasive detection of target substances using spectral filter arrays and image capture arrays |
| TW201734429A (zh) * | 2016-02-12 | 2017-10-01 | 摩杜雷特影像公司 | 用於評估組織血管健康之方法及裝置 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190133026A (ko) | 2019-11-29 |
| EP3573521A1 (en) | 2019-12-04 |
| SG11201908706QA (en) | 2019-10-30 |
| WO2018175787A1 (en) | 2018-09-27 |
| CN110573064B (zh) | 2023-01-06 |
| US20200107732A1 (en) | 2020-04-09 |
| KR102597974B1 (ko) | 2023-11-02 |
| TW201839379A (zh) | 2018-11-01 |
| CA3055768A1 (en) | 2018-09-27 |
| US11751769B2 (en) | 2023-09-12 |
| JP2020512852A (ja) | 2020-04-30 |
| JP7311424B2 (ja) | 2023-07-19 |
| CN110573064A (zh) | 2019-12-13 |
| EP3573521B1 (en) | 2022-12-28 |
| EP3573521A4 (en) | 2020-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI801370B (zh) | 用於評估糖尿病循環併發症之光學量測系統及估計組織血管健康之方法 | |
| KR102790135B1 (ko) | 조직 혈관 건강을 평가하는 방법 및 장치 | |
| JP6893877B2 (ja) | 組織を分類するための反射モードマルチスペクトル時間分解型光学イメージングの方法および装置 | |
| JP6785307B2 (ja) | 組織分類システム | |
| US20100210931A1 (en) | Method for performing qualitative and quantitative analysis of wounds using spatially structured illumination | |
| Weinkauf et al. | Near-instant noninvasive optical imaging of tissue perfusion for vascular assessment | |
| JP6596089B2 (ja) | アレルギー検査で使用するための方法及び機器 | |
| Tsai et al. | A noncontact skin oxygen-saturation imaging system for measuring human tissue oxygen saturation | |
| JP2018502677A5 (enExample) | ||
| CN111265188A (zh) | 一种基于局部微循环的糖尿病足风险评估装置及方法 | |
| Merdasa et al. | Oxygen saturation mapping during reconstructive surgery of human forehead flaps with hyperspectral imaging and spectral unmixing | |
| Li et al. | A reflectance model for non-contact mapping of venous oxygen saturation using a CCD camera | |
| El-Sharkawy | Advancements in non-invasive hyperspectral imaging: Mapping blood oxygen levels and vascular health for clinical and research applications | |
| KR101135067B1 (ko) | 레이노 현상 검사 장치 및 방법 | |
| Akimbekov et al. | An Overview of Quantitative Capillary Refill Time: Measurement and Application in Clinical Practice | |
| HK40019747A (en) | Systems and methods for assessing diabetic circulatory complications | |
| HK40002629B (en) | Method and apparatus for assessing tissue vascular health | |
| HK40019747B (en) | Systems and methods for assessing diabetic circulatory complications | |
| Zhang et al. | Convenient prediction of TcPO2 level using machine learning techniques with the PPG signal’s characteristic features | |
| HK40002629A (en) | Method and apparatus for assessing tissue vascular health | |
| Day et al. | Effect of Prolonged Pressure on Hemodynamics of Sacral Tissues Assessed by Diffuse Optical Imaging: A Pilot Study | |
| Anduig Romero | Investigations on the influence of superficial veins on camera-based photoplethysmograms |